Search Results
9 items found for "Neuroinflammation"
- Chemogenetic stimulation of the G i pathway in astrocytes suppresses neuroinflammation
In this study, we evaluated the role of the astrocytic Gi pathway in neuroinflammation using a Gi -coupled Gi -DREADD was expressed in hippocampal astrocytes of a lipopolysaccharide (LPS)-induced neuroinflammation We found that astrocyte Gi -DREADD stimulation using clozapine N-oxide (CNO) inhibits neuroinflammation Taken together, our results indicate that the astrocytic Gi pathway plays an inhibitory role in neuroinflammation , providing an opportunity to identify potential cellular and molecular targets to control neuroinflammation
- The microglial endocannabinoid system similarly regulated by lipopolysaccharide and interferon gamma
respond to cannabinoids which has implications for the development of cannabinoid-based treatments for neuroinflammation
- 📰 GPCR Weekly News, August 14 to 20, 2023
Disorders GPCRs in Oncology and Immunology Exacerbating effects of single-dose acute ethanol exposure on neuroinflammation
- Therapeutic validation of an orphan G protein‐coupled receptor
perception, reproduction, development, growth, metabolism, and are also linked to major diseases, such as neuroinflammatory pro‐inflammatory disorders renders it a promising target in inflammatory and fibrotic conditions, including neuroinflammation
- Exciting GPCR Events for Next Year! + GPCR Weekly Rocket Launch ⦿ Oct 28 - Nov 3, 2024
use disorders: Opportunities and hurdles for clinical development Chemokine CXCL13-CXCR5 signaling in neuroinflammation
- GPCR Updates: Celebrating Breakthroughs, New Course Launches Soon, and Exclusive Discounts! | Aug 26 - Sep 1, 2024
Board of Directors Adiso Announces Groundbreaking Research Highlighting ADS024 a Novel Oral Agent for Neuroinflammation
- Unlocking the Therapeutic Potential of Previously Undruggable GPCRs
Demonstration of the in vivo efficacy of a systemically administered antagonist analog in a model of neuroinflammation
- 📰 GPCR Weekly Buzz: Exciting Schedule Shifts for Principles of Pharmacology I & II | August 12-18, 2024
promote morning wakefulness LPA3 agonist-producing Bacillus velezensis ADS024 is efficacious in multiple neuroinflammatory
- Computational study of the conformational ensemble of CX3C chemokine receptor 1 (CX3CR1) and its...
multiple immunological cells such as microglia, macrophages and monocytes, and play a critical role in neuroinflammatory